Chief Legal Officer · Lexeo Therapeutics, Inc. · Common Stock
Side
SELL
Value
$5,089
Shares
549
Price
$9.27
Executed
Nov 18, 2025
Disclosed
Nov 20, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 18 executedNov 20, 2025 disclosed
LXEO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Robertson Jenny filed this Form 4 reporting a open-market sale of LXEO on Nov 18, 2025. It became public on Nov 20, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Legal Officer
Robertson Jennycik:0001995009
Issuer
Lexeo Therapeutics, Inc.cik:0001907108
Revision history · 0
No field has changed since this record was first ingested.
